Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Mehler-Wex

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Therapeutic Drug Monitoring|April 7, 2017
Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical PracticeStefanie Fekete, Christoph Wewetzer, Claudia Mehler-Wex, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 26, 2016
Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practiceChristopher Wohkittel, Manfred Gerlach, Regina Taurines, et al.
Pharmacopsychiatry|June 1, 2017
Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood DisordersLaura Albantakis, Karin Egberts, Rainer Burger, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 29, 2009
Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometryRegina Taurines, Edward Dudley, Alexander C Conner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 10, 2008
Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidoneChristian Fleischhaker, Philip Heiser, Klaus Hennighausen, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2006
Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neurolepticsChristian Fleischhaker, Philip Heiser, Klaus Hennighausen, et al.
European Child & Adolescent Psychiatry|November 7, 2009
Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophreniaRegina Taurines, Johannes Thome, J Catharina Duvigneau, et al.
Journal of Child and Adolescent Psychopharmacology|March 5, 2008
A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disordersBenno Graf Schimmelmann, Claudia Mehler-Wex, Martin Lambert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 30, 2020
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient careKarin Egberts, Su-Yin Reuter-Dang, Stefanie Fekete, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label studyRalf W Dittmann, Eberhard Meyer, Franz Joseph Freisleder, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|April 7, 2017
Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical PracticeStefanie Fekete, Christoph Wewetzer, Claudia Mehler-Wex, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 26, 2016
Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practiceChristopher Wohkittel, Manfred Gerlach, Regina Taurines, et al.
Pharmacopsychiatry|June 1, 2017
Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood DisordersLaura Albantakis, Karin Egberts, Rainer Burger, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 29, 2009
Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometryRegina Taurines, Edward Dudley, Alexander C Conner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 10, 2008
Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidoneChristian Fleischhaker, Philip Heiser, Klaus Hennighausen, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2006
Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neurolepticsChristian Fleischhaker, Philip Heiser, Klaus Hennighausen, et al.
European Child & Adolescent Psychiatry|November 7, 2009
Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophreniaRegina Taurines, Johannes Thome, J Catharina Duvigneau, et al.
Journal of Child and Adolescent Psychopharmacology|March 5, 2008
A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disordersBenno Graf Schimmelmann, Claudia Mehler-Wex, Martin Lambert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 30, 2020
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient careKarin Egberts, Su-Yin Reuter-Dang, Stefanie Fekete, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label studyRalf W Dittmann, Eberhard Meyer, Franz Joseph Freisleder, et al.
Pageof 4